Help Advance Research into Kidney Disease

Qualified people of African descent (including some Hispanics) could be the key to advancing the science of kidney disease treatment.


Research studies are enrolling today!

Those who qualify may receive:

  • Travel reimbursement.
  • No-cost care from local doctors and specialists.
  • No-cost study medication.

No health insurance or referral needed.

Those who qualify may receive:

Travel reimbursement.
No-cost care from local doctors and specialists.
No-cost study medication.
No health insurance or referral needed.

Take the next step to see if you qualify.

We are seeking adults of African descent with kidney disease to help assess investigational medicine. See if you are eligible.

globe icon

10% of the global population had chronic kidney disease (CKD) in 2015, which resulted in 1.2 million deaths globally.

group icon

Blacks are 3x more likely to have CKD while Hispanics of African decent are 1.3x more likely.

Africa Icon

70% of African Americans diagnosed with CKD had a genetic indicator called apolipoprotein L1 (APOL1), a gene that only occurs in those of African descent.

How does it work

Answer some questions
about your health

Tell us a little bit about yourself

Connect to available studies
in your area

Only takes a few minutes

AcurianHealth helps connect people with research studies that offer treatment under development.
Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.

 

©2024 Acurian, Inc. All rights reserved.

 

*In a research study, the participants may receive investigational study product or may receive an inactive substance, or placebo, depending on the study design. Participants receive study-related care from a doctor/research team for the duration of the study. For studies that offer compensation, reasonable payments will be made for participation. The length of the study may vary.

 

Terms of Use/Privacy Policy